Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.

Citation:
Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John Kinuthia, James N Kiarie, Njiri F, John-Stewart GC. "Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial." Antivir. Ther. (Lond.). 2008;13(6):799-807.

Abstract:

Defining the effect of antiretroviral regimens on breast milk HIV type-1 (HIV-1) levels is useful to inform the rational design of strategies to decrease perinatal HIV-1 transmission.

Notes:

n/a

UoN Websites Search